Science Market Update

Research News: UCLA Stem Cell Study Making a Sensation

Posted by Rebecca Inch-Partridge on Thu, Jan 18, 2018

Most people think of paralysis in terms of not being able to move or walk. But there is another side to being paralyzed , the lack of sensation. The inability to feel pain leaves the person susceptible to burns from inadvertent contact with hot surfaces. Researchers at the Broad Center for Regenerative Medicine and Stem Cell Research at UCLA have developed a new protocol which could serve as the first step toward stem cell-based therapies to restore sensation in paralyzed people who have lost feeling in parts of their body.

Read More

Tags: Stem cell research, LAVS, UCLA, laboratory equipment suppliers, Lab Product Sales, research news, UC Los Angeles, BioResearch Product Faire, UCLA research funding, general lab supply, 2017 research funding, nih research funding

University of California Strengthens Cancer Research with Creation of New 5-School Consortium

Posted by Laura Braden on Mon, Oct 23, 2017

In the state of California, more than 176,000 residents arediagnosed with cancer each year and more than $14 billion is spent to fight this disease in California alone. The University of California system has five of the top cancer centers in the country within theseacademic institutions. In September these five UC cancer centers announced that they were teaming up to form a cancer consortium to provide researchers and physicians in California more opportunities to further their work on cancer-related topics. (Image courtesy of Wikimedia Commons)

Read More

Tags: cancer research, University of California, LAVS, SDVS, UCDMC, SFVS, BioResearch Product Faire Event, UCI, Biotechnology Vendor Showcase Event, 2018

$8M Granted to UCLA to Study Cytomegalovirus and Kidney Transplants

Posted by Laura Braden on Thu, Oct 05, 2017

Organ transplants are common surgeries that happen around the world. In the United States, more than 33,000 transplants occurred in 2016, with more than half of these being kidney transplants. Although the majority of people come out of transplant surgery with no problems, many develop serious infections caused by the common virus cytomegalovirus (CMV)when the immune system rejects the new kidney.

Read More

Tags: CA, new research funding, LAVS, UCLA, Biotechnology Vendor Showcase, NIH funding, 2017, cytomegalovirus

UCLA Leading $20M Project to Decrease Growing HIV Infection Rate Among Youths

Posted by Rebecca Partridge on Thu, Aug 10, 2017

“Despite dramatic improvements in the ability to treat and prevent HIV, the HIV rate among youth in America has doubled in the last 10 years,” Mary Jane Rotheram-Borus, director of the Global Center for Children and Families at UCLA stated in a recent article for the UCLA Newsroom. By 2020 the incidence of the disease among youths is expected to increase by 39%. Dr. Rotheram-Boras believes that if acutely infected youths were identified and treated during the period when their infectivity to others is 5-10 fold, then the medical community could reverse this trend and improve the long-term health of youths.  

(Image of UCLA courtesy of Wikimedia

Read More

Tags: LAVS, UCLA, Laboratory Equipment Supplier, Lab Product Sales, NIH grants, UC Los Angeles, BioResearch Product Faire, UCLA research funding, Laboratory product sales, general lab supply, 2017 research funding

UCLA Increasing Cannabis Research With Newly Established Research Group

Posted by Laura Braden on Tue, Aug 08, 2017

As cannabis use becomes legal in more and more states in the US, both for recreational and medical purposes, it is becoming necessary for more research into the drug. Currently in the US, 20% of the population have access to legal recreational marijuana use and 60% have access to legal medical marijuana. Unfortunately, even with such widespread access to cannabis, research if the drug has been limited due to the DEA classifying it as a Schedule I drug in the 1970s. (Image courtesy of CC BY-SA 3.0 via Wikimedia Commons)

Read More

Tags: University of California Los Angeles, Cannabinoids, LAVS, UCLA, Biotechnology Vendor Showcase Event, 2017, cannabis research

UCLA: Medical Building Reopens After $65M Renovation

Posted by Rebecca Partridge on Thu, Jun 01, 2017

On April 20th UCLA celebrated the grand reopening of the Jules Stein Building after a $65M renovation. This building connects to the Doris Stein Building and the Edie & Lew Wasserman Building to make up the UCLA Stein Eye Institute. Combined, the three buildings provide nearly 300,000 square feet of functional space with over 20 specially equipped laboratories to support vision science investigations.

Read More

Tags: University of California Los Angeles, LAVS, UCLA, Laboratory Equipment Supplier, Lab Product Sales, new medical buildings, BioResearch Product Faire, David Geffen School of Medicine

Funding News: $50M Gift from Mattel to Benefit UCLA Hospital

Posted by Rebecca Partridge on Wed, Apr 26, 2017

In 1998 Mattel’s gift of $25 million made the construction of the UCLA Mattel Children’s Hospital possible. In March 2017 Mattel made a $50M commitment to the UCLA Foundation to expand the hospital’s pediatric services.  Over the last 20 years, Mattel has provided more than $80 million to UCLA’s health care system to support its Children’s Hospital.

(Image of Dr. John Mazziotta, vice chancellor of UCLA Health Sciences and Richard Dickson, president of Mattel, announcing the $50 million gift courtesy of UCLA Newsroom) 

Read More

Tags: LAVS, UCLA, Lab Product Sales, UC Los Angeles, BioResearch Product Faire, 2017 research funding, UCLA hospital

UCLA Researchers: New Evidence for Novel Method of Cancer Metastasis

Posted by Greg Paul on Fri, Aug 26, 2016

Researchers from UCLA and partnering schools guided by Laurent Bentolila found evidence supporting the spread of malignant cells through angiotropism with vascular co-option, and even suggested they may be related or identical processes.  These findings were published in Nature Scientific Reports. With angiotropism being the ability for cells to travel along surface of blood vessels, but not be inside of them, also called extravascular migratory metastasis (EVMM) and vascular co-option being the ability for a tumor to use a blood supply and travel along it, this means cancer has an outlet to spread outside of the bloodstream.  The spread outside of the bloodstream means some current methods of treating cancer would be ineffective.

“... if the metastasizing cells are on the outside of the blood vessels, they escape exposure to the treatment and continue to spread cancer.”

-Laurent A. Bentolila

Read More

Tags: CA, University of California Los Angeles, cancer research, Los Angeles, Cancer, LAVS, UCLA, laboratory, lab products, 2016

UCLA Life Science: Biochemists Convert Glucose Without the Help of Cells

Posted by Laura Braden on Mon, Jul 11, 2016

A team of biochemists at UCLA have created a novel system of converting glucose into highly useful chemical compounds, such as those needed to create biofuels and pharmaceuticals. Previous research endeavors relied on using cells to convert sugar into desired compounds. This has been difficult to achieve because cells would rather use sugar for their own natural uses, such as building proteins and cell walls. The UCLA biochemists have recently developed a way to achieve the conversion of glucose into desired compounds- without using cells.

Read More

Tags: CA, University of California Los Angeles, Los Angeles, Biochemistry, chemistry research, Chemistry, LAVS, UCLA, Biotechnology Vendor Showcase, 2016, Western, glucose

UCLA Receives $1M Donation for Lung Disease Treatments

Posted by Laura Braden on Mon, Jan 25, 2016

When vital organs in the body, such as the lungs, begin to fail, an organ transplant can be a solution to the problem. However, receiving a transplant may have its own complications, such as the body rejecting its new organ.

Now, thanks to a generous donation of $1 million dollars from Michael and Linda Keston, researchers from the Division of Pulmonary and Critical Care Medicine at the UCLA David Geffen School of Medicine will be able to continue studying lung disease and the organ rejection commonly following a transplant. 

Read More

Tags: CA, University of California Los Angeles, Los Angeles, LAVS, UCLA, Biotechnology Vendor Showcase, new funding, 2016, Lung Disease, organ transplant, organ rejection

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News